Results 181 to 190 of about 497,334 (328)

Dendritic cells and HIV transmission: roles and subsets of antigen-presenting cells in the human anogenital tract. [PDF]

PLoS Pathog
Buffa DJ, O'Neil TR, Vine EE, Sarkawt L, Warner van Dijk FA, Dong OA, Nasr N, Cunningham AL, Bertram KM, Harman AN.   +9 more
europepmc   +1 more source

HLA-DQ-restricted CD4+ T cells specific to streptococcal antigen present in low but not in high responders. [PDF]

, 1991
Nobuhiro Kamikawaji, Kazuki Fujisawa, Hideyuki Yoshizumi, M Fukunaga, Michio Yasunami, Akinori Kimura, Y. Nishimura, T. Sasazuki   +7 more
openalex   +1 more source

Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Ocrelizumab (OCR), a humanized anti‐CD20 monoclonal antibody, is highly efficient in relapsing–remitting multiple sclerosis (RR‐MS). We assessed early cellular B‐cell profiles in patients prior to OCR treatment, on OCR treatment, and after 15 months of therapy discontinuation.
Alexandra Garcia, Stephane Rodriguez, Emilie Dugast, Christine Lebrun‐Frenay, Eric Thouvenot, Jérôme de Sèze, Emmanuelle Le Page, Sandra Vukusic, Inès Doghri, Eric Berger, Olivier Casez, Pierre Labauge, Aurélie Ruet, Catarina Raposo, Fabienne Le Frère, Arnaud B. Nicot, Sandrine Wiertlewski, Pierre‐Antoine Gourraud, Laure Michel, Laureline Berthelot, David‐Axel Laplaud   +20 more
wiley   +1 more source

Diatom-Based Artificial Antigen-Presenting Cells: A Novel Approach for Adaptive Immune Modulation. [PDF]

ACS Appl Mater Interfaces
Abdul Rahman A, Mohd Isa IL, Biggs MJ, Pandit A.   +3 more
europepmc   +1 more source

Identification of a rabies virus T cell epitope on the basis of its similarity with a hepatitis B surface antigen peptide presented to T cells by the same MHC molecule (HLA-DPw4). [PDF]

, 1990
Esteban Celis, J K Larson, L. Ötvös, William H. Wunner   +3 more
openalex   +1 more source

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin, Gregory Sahagian, Marc H. Feinberg, C. Andrew Stewart, Christopher M. Jewell, Metin Kurtoglu, Miloš D. Miljković, Tuan Vu, Tahseen Mozaffar, James F. Howard Jr, the MG‐001 Study Group   +10 more
wiley   +1 more source

Assessment of antigen immunogenicity formulated in minigenes transfected into antigen-presenting cells. [PDF]

PLoS One
Villota-Alava MA, Alfaro-Marenco MA, Clavijo-Ramírez CA, Patarroyo MA, Parra-López CA.   +4 more
europepmc   +1 more source

Cholesterol Metabolism in Antigen-Presenting Cells and HIV-1 Trans-Infection of CD4⁺ T Cells. [PDF]

Viruses, 2023
Okpaise D, Sluis-Cremer N, Rappocciolo G, Rinaldo CR.   +3 more
europepmc   +1 more source

Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. [PDF]

, 1993
Patrick G. Holt, J. Oliver, N. Bilyk, Christine McMenamin, Paul G. McMenamin, Georg Kraal, Theo Thepen   +6 more
openalex   +1 more source

NR4A1 Exerts Pro‐Tumor Role in Glioblastoma via Inducing xCT/GPX4‐Regulated Ferroptosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Purpose This study investigates NR4A1's paradoxical roles in glioblastoma (GBM) progression, focusing on its mechanistic link to ferroptosis regulation. We aimed to resolve conflicting reports of NR4A1 as both an oncogene and a tumor suppressor by defining its transcriptional control over xCT/GPX4‐mediated iron homeostasis and its clinical ...
Peng Tao, Shikuan Din, Zhengkang Fu, Qian Sun, Xiwei Zhu, Yuxin Wei, Huan Qu, Xinyi Zhang, Jiaxuan Liu, Chuhua Fu, Qianxue Chen   +10 more
wiley   +1 more source